← All trials
NCT06063057
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 20, 2023
- Primary completion
- Dec 17, 2024
- Completion date
- Apr 10, 2025
- First posted
- Oct 2, 2023
- Last posted
- Oct 2, 2023
- Enrollment
- 744
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Sinovac Biotech Co., LtdLead sponsor
- Government of ChinaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.